Adaptive designs in clinical trials are by now a well-established tool to efficiently design clinical trials. In some scenarios they offer the flexibility of modifying trials during the trial, after one or more interim analyses, i.e., once partial data are collected.
Using real-world examples from the pharmaceutical industry, this virtual course provides a comprehensive review of the concepts and methods underpinning adaptive clinical designs and examines their application in drug development. It will also provide an overview of data monitoring and regulatory guidance relevant to adaptive designs.
Course on two half-days.